
Pharmacia May Pay $212M in Medicaid Fraud Case
Pfizer's Pharmacia unit may be ordered to pay nearly $212 million as a result of a February 2009 Wisconsin court ruling that found the company guilty of violating the state's Medicaid fraud statute 1.44 million times.
Pfizer’s Pharmacia unit may be ordered to pay nearly $212 million as a result of a February 2009 Wisconsin court ruling that found the company guilty of violating the state’s Medicaid fraud statute 1.44 million times. Last week, Wisconsin’s Attorney General J.B. Van Hollen requested
The $212 million would be in addition to the
According to the government’s allegations, Pharmacia published false average wholesale prices (AWPs), which caused the state to overpay for prescription drugs. According to the Wisconsin Department of Justice, “The jury verdict confirmed the allegation that Pharmacia benefited from the scheme because it was able to attract business and market its pharmaceuticals to healthcare providers by using the inflated prices to reimburse the providers far more than they actually paid for the drugs. As a result, Pharmacia increased its market share and profits. Meanwhile Medicaid was paying a price based on the grossly inflated, fraudulent AWP.”
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





